Advertisement
Journal Home
Search for

Volume 135, Issue 3, Pages 390-393 (10 July 2009)


View previous. 19 of 36 View next.

Does a low sodium diet modify heart rate variability? A randomised placebo-controlled double-blind trial

Zara E.K. PogsonaCorresponding Author Informationemail address, Tricia M. McKeevera, Sarah A. Lewisa, Sarah J. Paceyb, Marilyn D. Antoniaka, John R. Brittona, Andrew W. Fogartya

Received 27 October 2008; accepted 1 November 2008. published online 08 December 2008.

Abstract 

Background

Increased heart rate variability (HRV) is associated with a low risk of mortality, as is consuming a low sodium diet. As the survival benefits of a low sodium diet may be mediated partly by an increase in HRV, we have tested the hypothesis that adopting a low sodium diet increases HRV.

Methods

We used a randomised double-blind placebo-controlled trial design. Participants were aged 18–65 years old, had a physician diagnosis of asthma. All adopted a low sodium diet and they were randomised to receive either 80 mmol/day of oral sodium supplements (normal sodium intake — NSI) or matched placebo (low sodium intake—LSI) for 6 weeks. The primary outcome was change in SDNN (standard deviation of the NN intervals); secondary outcomes were changes in other time domain and frequency domain measures of HRV.

Results

In those allocated to the LSI, mean daily urinary sodium excretion decreased by 22 mmol; and in those allocated to the NSI mean daily urinary sodium excretion increased by 31 mmol. There were no differences between the two groups for either the primary or secondary outcome measures. The mean difference in change in SDNN between those who received the LSI compared to the NSI was −2.7 ms (95% Confidence Intervals CI; −18.0 to +12.6).

Conclusions

Adopting a low sodium diet does not have an impact on SDNN over a 6 weeks period. Future studies should aim to achieve a larger change in dietary sodium intake for a longer duration than 6 weeks.

a Division of Epidemiology and Public Health, University of Nottingham, Clinical Sciences Building, City Hospital, Nottingham,NG5 1PB, United Kingdom

b Department of Pharmacy, Nottingham City Hospital, Nottingham University Hospitals NHS Trust, Hucknall Road, Nottingham, NG5 1PB, United Kingdom

Corresponding Author InformationCorresponding author. Division of Epidemiology and Public Health, Clinical Sciences Building, Nottingham City Hospital, Hucknall Road, Nottingham, NG5 1PB, United Kingdom. Tel.: +44 115 8231935; fax: +44 115 8231946.

PII: S0167-5273(08)01174-1

doi:10.1016/j.ijcard.2008.11.004


View previous. 19 of 36 View next.